CYTOTOXIC-CELL ANTIGEN EXPRESSION IN ANAPLASTIC LARGE-CELL LYMPHOMAS OF T-CELL AND NULL-CELL TYPE AND HODGKINS-DISEASE - EVIDENCE FOR DISTINCT CELLULAR-ORIGIN
L. Krenacs et al., CYTOTOXIC-CELL ANTIGEN EXPRESSION IN ANAPLASTIC LARGE-CELL LYMPHOMAS OF T-CELL AND NULL-CELL TYPE AND HODGKINS-DISEASE - EVIDENCE FOR DISTINCT CELLULAR-ORIGIN, Blood, 89(3), 1997, pp. 980-989
Anaplastic large cell lymphoma (ALCL) is composed of large, frequently
bizarre, cells of T- or null-cell phenotype that show a preferential
sinusoidal growth pattern and consistent CD30 positivity. Whether thes
e tumors represent a single entity or several, and what the exact cell
origin, is controversial. Recently, granzyme B, a cytotoxic granule c
omponent, was reported in a small percentage of ALCL, suggesting that
some cases may originate from cytotoxic lymphocytes. To further invest
igate this possibility, we performed an immunohistochemical study of 3
3 ALCLs of T- and null-cell type, using monoclonal antibodies to cytot
oxic cell-associated antigens, including CD8, CD56, CD57, and the cyto
toxic granular proteins perforin and TIA-1. In addition, CD4 expressio
n was also evaluated. ALCL cases included 27 classical systemic forms
and variants, 3 primary cutaneous (PC) forms, and 3 acquired immunodef
iciency syndrome-associated forms. Cytotoxic antigen expression was al
so studied in 51 cases of Hodgkin's disease (HD) and 17 large B-cell l
ymphomas (LBCLs) with anaplastic cytomorphology and/or CD30 positivity
. We found that 76% of ALCLs, representing all subtypes except the PC
forms, expressed either TIA-1, perforin, or both proteins. Expression
of TIA-1 and perforin were highly correlated (P < .001). On the basis
of their immunophenotypic profiles, several subtypes of cytotoxic anti
gen positive and negative ALCL could be recognized. Fifty-five percent
of ALCLs (18 of 33) displayed an immunophenotypic profile consistent
with cytotoxic T cells. Six cases expressed cytotoxic granular protein
s in the absence of lineage specific markers, and one case expressed b
oth T-cell- and natural killer cell-like markers. These 7 cases (21%)
were placed into a phenotypic category of cytotoxic lymphocytes of uns
pecified subtype. Twenty-four percent (8 cases) of ALCLs were cytotoxi
c granule protein negative. All but one of these displayed a T-cell ph
enotype. Cytotoxic granule protein expression did not correlate with t
he presence of the NPM-ALK fusion transcript. Only 10% of the 51 HD ca
ses were found to be TIA-1(+), and none expressed perforin. Cytotoxic
antigen expression was absent in LBCL. The expression of cytotoxic gra
nule proteins in the majority of ALCL implies a cytotoxic lymphocyte p
henotype and suggests that most cases originate from lymphocytes with
cytotoxic potential. Furthermore, the demonstration of cytotoxic cell
related proteins may be a useful addition to the current panel of anti
bodies used to distinguish ALCL, HD, and anaplastic LBCL. This is a US
government work. There are no restrictions on its use.